Biggest News Aggregation in the World
📰 Rob Volansky News

Page 2 - Rob Volansky News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rob Volansky. Real-time updates on events, politics, business and more.

'Disappointing' data reveal modest benefit of exercise over pain meds in knee OA

A meta-analysis comparing exercise, opioids and NSAIDs yielded “disappointing” and inconsistent results, in which exercise generally demonstrated some benefit over opioids and NSAIDs, according to a speaker at the 2022 OARSI World Congress.
Rob Volansky Carstenb Juhl University Of Southern Denmark World Congress World Congress On Osteoarthritis Southern Denmark
Source: healio.com

Deciphering telltale signs, symptoms of non-radiographic axial SpA remains a challenge

Given the limited awareness of non-radiographic axial spondyloarthritis, differentiating this disease from radiographic disease and prescribing appropriate therapy remains a key challenge, according to a presentation at the Biologic Therapies Summit. “Epidemiological knowledge in the United States about this disease is limited,” Marina Magrey, MD, the rheumatology fellowship program
United States Rob Volansky Eli Lilly Marina Magrey Eli Lilly Co Biologic Therapies Summit
Source: healio.com

Medical research 'just starting to scratch the surface' on cytokine storm syndrome

While COVID-19 launched cytokine storm syndrome to the forefront of medical research, there is still much to be learned about these hyperactive immune events, according to a presenter at the Biologic Therapies Summit.“A cytokine storm is an immune dysregulation that causes collateral damage,” David Fajgenbaum, MD, MBA, MSc, assistant professor at the Perelman School of Medicine at the
Rob Volansky David Fajgenbaum Eusa Pharma University Of Pennsylvania Perelman School Of Medicine Biologic Therapies Summit
Source: healio.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

'Therapeutic headway' still lacking for rare VEXAS disease

Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio VEXAS syndrome is a recently discovered disease that features fever, orchitis, skin nodules and small- or medium-vessel vasculitis, among other symptoms, according to a presenter at the Biologic Therapies Summit. Peter Grayson, MD , head of the vasculitis translational research program and associate director of the NIAMS Fe...
Peter Grayson Rob Volansky Fellowship Program Biologic Therapies Summit Biologic Therapies பீட்டர் கிரேசன்
Source: healio.com

Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis

Tocilizumab holds firm as steroid-sparing agent in giant cell arteritis Source: Warrington K. When should biologic agents be introduced in giant cell arteritis and for how long should they be given? Presented at: Biologic Therapies Summit IX; May 21-23, 2021 (virtual meeting). Disclosures: Warrington reported no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email addre...
United States Mayo Clinic In Rochester Rob Volansky Actemra Gi Kennethj Warrington Vasculitis Foundation
Source: healio.com

OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting

OARSI Joint Effort Initiative seeks to improve remote, online care in COVID-19 setting Source: Quicke. The OARSI "Joint Effort Initiative" Repository of Online Osteoarthritis Management Programmes: An Implementation Rapid Response During COVID-19. Presented at: OARSI 2021 World Congress on Osteoarthritis; April 29-May 1. (virtual meeting). Disclosures: Quicke reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles...
United Kingdom Jonathang Quicke Rob Volansky Effort Initiative Keele University Keele University In Staffordshire
Source: healio.com

'No need' to suspend immunosuppressive drugs due to COVID-19: No impact on risk outcomes

Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio It is only natural that individuals taking immunosuppressive medications would fear COVID-19. However, recent findings add to a growing body of data indicating that immunosuppression may not elevate risk for worse outcomes for COVID-19 hospitalization. “This is a small amount of good news at a time in this pandemic...
United States Kayte Andersen Rob Volansky Johns Hopkins G Caleb Alexander Johns Hopkins University
Source: healio.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science